Surging Running Trend Prompts Pyridam Farma (PYFA) to Urge Indonesian Runners to Protect Joints and Bones Early On

4 min read

KEY POINTS:

JAKARTA, October 15, 2026 – PT Pyridam Farma Tbk (IDX: PYFA), through its PYFAHEALTH brand line, has introduced a range of musculoskeletal supplement products designed for active individuals, particularly those participating in high-impact sports like running. The lineup features three complementary products: Caltron to help maintain bone health, Osteor Plus to support joint health, and Syalox 300 P, which also assists in maintaining joint health. All three are designed as preventive measures so recreational runners can scale up training intensity without compromising long-term joint and bone wellness.

Indonesians’ interest in running has surged dramatically over the past three years. According to the official website of Bank Tabungan Negara (BTN), the BTN Jakarta International Marathon (BTN Jakim) recorded a massive increase in participants—growing from approximately 15,000 runners in 2024 to 31,000 in 2025, and exceeding 45,000 runners during the June 13–14, 2026 edition, which included 1,012 international runners from 52 countries. Furthermore, official reports from an Indonesian national daily note a similar trend at the myBCA Jakarta Running Festival (JRF), where participation rose from 27,300 runners in 2025 to over 37,000 in 2026. At BTN Jakim 2026, the half marathon category (21K) emerged as the most popular, indicating that Indonesian runners are increasingly moving beyond short distances toward long-distance events that demand significantly greater structural endurance. This shift highlights the urgent need for education regarding joint and bone readiness.

Behind this rapidly growing trend lies a fundamental factor that amateur runners frequently overlook: the tolerance limit of the musculoskeletal system. Many sports enthusiasts focus solely on building speed, extending distance, or increasing workout intensity, forgetting that bones, joints, ligaments, and muscles have absolute physical limits in absorbing repetitive mechanical stress. For those transitioning quickly from a sedentary lifestyle to high-intensity training, accelerating workout loads too rapidly can trigger progressive tissue damage and deplete the knee’s natural lubricants.

PYFA Medical Expert Dr. Carlinda Nekawaty pointed out that insufficient nutritional intake for bones and joints is often a primary cause of the high injury rate among recreational runners. Therefore, protecting the body’s structural framework from within is an essential preventive measure to maintain optimal mobility before increasing training demands.

“Many people are becoming passionate about endurance sports like marathon running, yet they often fail to supply their bodies with adequate nutrition. If joint pain—especially in the knees—begins to manifest and is pushed through continuously without proper management, it significantly increases the risk of injury complications that threaten long-term mobility. It is vital for runners to understand what their bodies require to prevent joint degradation, covering everything from vitamins and minerals to holistic joint lubrication,” stated Dr. Carlinda.

Each of the three PYFAHEALTH products targets a distinct layer of protection. Osteor Plus contains D-glucosamine sulfate potassium (shrimp & crab shell) 500 mg and chondroitin SO4 Sod (shark) 400 mg—key components of cartilage building blocks—complemented by MSM (as Methylsulfonylmethane) 350 mg, vitamin C 50 mg, as well as magnesium, zinc, manganese, and selenium to help support overall joint health. Syalox 300 P features a triple-layer tablet combining 300 mg of sodium hyaluronate—a core element of synovial fluid that acts as a joint cushion and lubricant—with 100 mg of Boswellia serrata gum resin extract. Syalox 300 P stands as the first oral combination of sodium hyaluronate and Boswellia serrata in Indonesia formulated to help maintain joint health. Meanwhile, Caltron delivers a blend of vitamins and minerals to support bone health, which is critical for runners given the repetitive impact force sustained with every stride.

Sustaining long-term performance is far more important than forcing oneself across the finish line with a vulnerable structural frame. The body requires dedicated recovery strategies and nutritional support starting from the early preparation phase. Ensuring adequate internal nutritional intake is an essential step toward keeping bones and joints in peak condition while running.

PYFA remains dedicated to educating running communities and fitness enthusiasts across Indonesia on the principles of proper sports medicine. The company has expanded its holistic joint health campaign through the BoneVestment bone density screening program, aiming to help the public safely enjoy this positive sports movement for years to come.

About PYFA

PT Pyridam Farma Tbk, also known as PYFA, is a public pharmaceutical company listed on the Indonesia Stock Exchange (Ticker: PYFA). PYFA operates several business units producing prescription medicines in various forms, including tablets, capsules, creams, and injections. PYFA also has several well-known subsidiaries, including PT Holi Pharma, PT Ethica Industri Farmasi, and Probiotec Multipack.